IT8767566A0 - Idrato cristallino di acido 7 beta 72 2 amminotiazol 4 il 4 carbossi but 2 enoilammino 3 cefem 4 carbossilico procedimento per il suo ottenimento confezione per capsule di gelatina contenente detto idrato eprocedimento per l ottenimento di detta composizione - Google Patents

Idrato cristallino di acido 7 beta 72 2 amminotiazol 4 il 4 carbossi but 2 enoilammino 3 cefem 4 carbossilico procedimento per il suo ottenimento confezione per capsule di gelatina contenente detto idrato eprocedimento per l ottenimento di detta composizione

Info

Publication number
IT8767566A0
IT8767566A0 IT8767566A IT6756687A IT8767566A0 IT 8767566 A0 IT8767566 A0 IT 8767566A0 IT 8767566 A IT8767566 A IT 8767566A IT 6756687 A IT6756687 A IT 6756687A IT 8767566 A0 IT8767566 A0 IT 8767566A0
Authority
IT
Italy
Prior art keywords
obtaining
procedure
hydrate
acid
enoylamino
Prior art date
Application number
IT8767566A
Other languages
English (en)
Other versions
IT1211469B (it
Inventor
Hamashima Kyoji Minami Yoshio
Kawata Teruo Sakamoto Kyozo
Takeda Yusuke Suzuki Toyohiko
Tujikawa Masanori
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja
Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IT8767566A0 publication Critical patent/IT8767566A0/it
Application granted granted Critical
Publication of IT1211469B publication Critical patent/IT1211469B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
IT8767566A 1986-07-02 1987-07-01 Idrato cristallino di acido 7 beta 72 2 amminotiazol 4 il 4 carbossi but 2 enoilammino 3 cefem 4 carbossilico procedimento per il suo ottenimento confezione per capsule di gelatina contenente detto idrato eprocedimento per l ottenimento di detta composizione IT1211469B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61156954A JP2544113B2 (ja) 1986-07-02 1986-07-02 安定なカプセル製剤
JP21626086A JPH0717651B2 (ja) 1986-09-12 1986-09-12 経口投与用セフアロスポリン水和物結晶

Publications (2)

Publication Number Publication Date
IT8767566A0 true IT8767566A0 (it) 1987-07-01
IT1211469B IT1211469B (it) 1989-11-03

Family

ID=26484565

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8767566A IT1211469B (it) 1986-07-02 1987-07-01 Idrato cristallino di acido 7 beta 72 2 amminotiazol 4 il 4 carbossi but 2 enoilammino 3 cefem 4 carbossilico procedimento per il suo ottenimento confezione per capsule di gelatina contenente detto idrato eprocedimento per l ottenimento di detta composizione

Country Status (27)

Country Link
US (2) US4812561A (it)
KR (1) KR950005302B1 (it)
CN (1) CN1015106B (it)
AR (1) AR243893A1 (it)
AT (1) AT392472B (it)
AU (1) AU594167B2 (it)
BE (1) BE1001691A4 (it)
CA (1) CA1283405C (it)
CH (1) CH672788A5 (it)
DE (1) DE3721913A1 (it)
DK (1) DK161080C (it)
ES (2) ES2004952A6 (it)
FI (1) FI89052C (it)
FR (1) FR2601014B1 (it)
GB (1) GB2192183B (it)
GR (1) GR871014B (it)
HK (1) HK47893A (it)
HU (1) HU200777B (it)
IE (1) IE59613B1 (it)
IL (1) IL83059A (it)
IT (1) IT1211469B (it)
NL (1) NL193136C (it)
NO (1) NO170889C (it)
NZ (1) NZ220764A (it)
PL (1) PL159180B1 (it)
RU (1) RU1829932C (it)
SE (1) SE466257B (it)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
RU2123863C1 (ru) * 1992-04-30 1998-12-27 Шеринг Корпорейшн Содержащая гидратированный цефтибутен порошковая антибактериальная композиция, предназначенная для орального использования в виде суспензии
CA2314140A1 (en) * 1998-10-27 2000-05-04 Randal Ray Ford Process for the polymerization of olefins; novel polyethylenes, and films and articles produced therefrom
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US8313775B2 (en) * 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313776B2 (en) * 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
AU2004264939A1 (en) * 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
EP1653924A4 (en) * 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSE DISTRIBUTION
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
CA2833852C (en) 2005-11-11 2014-10-21 Boehringer Ingelheim International Gmbh Quinazoline derivatives for the treatment of cancer diseases
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
AU2007339382B2 (en) 2006-12-22 2013-05-02 Merck Sharp & Dohme Llc 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
CN101611002A (zh) * 2006-12-22 2009-12-23 先灵公司 用于治疗或预防hcv和相关病毒感染的4,5-环化吲哚衍生物
WO2008136815A2 (en) 2006-12-22 2008-11-13 Schering Corporation 5, 6-ring annulated indole derivatives and use thereof
CN101842374A (zh) 2007-08-29 2010-09-22 先灵公司 用于治疗病毒感染的2，3-取代的氮杂吲哚衍生物
US8143305B2 (en) * 2007-08-29 2012-03-27 Schering Corporation 2,3-substituted indole derivatives for treating viral infections
AU2008295484B2 (en) 2007-08-29 2013-09-26 Merck Sharp & Dohme Llc Substituted indole derivatives and methods of use thereof
CN102099351A (zh) * 2007-11-16 2011-06-15 先灵公司 3-杂环取代的吲哚衍生物及其使用方法
US8377928B2 (en) * 2007-11-16 2013-02-19 Merck Sharp & Dohme Corp. 3-aminosulfonyl substituted indole derivatives and methods of use thereof
WO2009152200A1 (en) * 2008-06-13 2009-12-17 Schering Corporation Tricyclic indole derivatives and methods of use thereof
JP5619743B2 (ja) 2008-08-20 2014-11-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． エテニル置換ピリジンおよびピリミジン誘導体およびウイルス感染の治療におけるそれらの使用
WO2010022125A1 (en) 2008-08-20 2010-02-25 Schering Corporation Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8470834B2 (en) 2008-08-20 2013-06-25 Merck Sharp & Dohme Corp. AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
TWI409265B (zh) 2008-08-20 2013-09-21 Merck Sharp & Dohme 經取代之吡啶及嘧啶衍生物及彼等於治療病毒感染之用途
JP2012528195A (ja) 2009-05-29 2012-11-12 メルク・シャープ・アンド・ドーム・コーポレーション Ｃ型肝炎などの疾患を処置するための３つの結合アリール部分で構成された抗菌性化合物
DK2451445T3 (da) 2009-07-06 2019-06-24 Boehringer Ingelheim Int Fremgangsmåde til at tørre bibw2992, dets salte og faste farmaceutiske formuleringer omfattende denne aktive ingrediens
JP2013512246A (ja) 2009-11-25 2013-04-11 メルク・シャープ・アンド・ドーム・コーポレーション ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
US20130156731A1 (en) 2009-12-22 2013-06-20 Kevin X. Chen Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
EP2536410B1 (en) 2010-02-18 2015-09-23 Merck Sharp & Dohme Corp. Substituted pyrimidine derivatives and their use in treating viral infections
JP2013522202A (ja) 2010-03-09 2013-06-13 メルク・シャープ・エンド・ドーム・コーポレイション 縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法
WO2011139253A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
US20140377223A1 (en) 2010-07-26 2014-12-25 Joseph A. Kozlowski Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
EP2621279B1 (en) 2010-09-29 2018-04-04 Merck Sharp & Dohme Corp. Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
WO2012142075A1 (en) 2011-04-13 2012-10-18 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
AU2012242970A1 (en) 2011-04-13 2013-10-24 Merck Sharp & Dohme Corp. 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013151518A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
WO2015065817A1 (en) 2013-10-30 2015-05-07 Merck Sharp & Dohme Corp. Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) * 2014-04-17 2016-03-16 海南日中天制药有限公司 一种头孢克肟组合物及其制备方法
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions
CA3022684A1 (en) 2016-05-13 2017-11-16 Aeromics, Inc. Crystals
CN106397454B (zh) * 2016-08-30 2018-08-24 山东罗欣药业集团股份有限公司 一种抗感染药物头孢布烯晶型化合物及其组合物
CN106397457A (zh) * 2016-09-21 2017-02-15 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432271A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432270A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106432272A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
WO2023278945A1 (en) * 2021-07-01 2023-01-05 Qpex Biopharma, Inc. Crystalline forms of ceftibuten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) * 1980-07-22 1982-02-12 Fujisawa Pharmaceut Co Ltd Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters

Also Published As

Publication number Publication date
AT392472B (de) 1991-04-10
NO170889C (no) 1992-12-23
PL159180B1 (pl) 1992-11-30
KR950005302B1 (ko) 1995-05-23
NO872729D0 (no) 1987-06-30
SE8702705L (sv) 1988-01-03
IE871738L (en) 1988-01-02
SE466257B (sv) 1992-01-20
AU7504087A (en) 1988-01-07
IL83059A0 (en) 1987-12-31
NO170889B (no) 1992-09-14
IT1211469B (it) 1989-11-03
CA1283405C (en) 1991-04-23
AU594167B2 (en) 1990-03-01
NL193136C (nl) 1998-12-04
FI872903L (fi) 1988-01-03
ES2004952A6 (es) 1989-02-16
DK161080B (da) 1991-05-27
BE1001691A4 (fr) 1990-02-13
FR2601014B1 (fr) 1990-09-14
HK47893A (en) 1993-05-27
SE8702705D0 (sv) 1987-06-30
CH672788A5 (it) 1989-12-29
DK336487D0 (da) 1987-06-30
FR2601014A1 (fr) 1988-01-08
KR880001670A (ko) 1988-04-26
US4812561A (en) 1989-03-14
US4933443A (en) 1990-06-12
PL266567A1 (en) 1988-07-21
DE3721913A1 (de) 1988-01-07
GB2192183B (en) 1990-05-16
FI89052B (fi) 1993-04-30
IE59613B1 (en) 1994-03-09
DK161080C (da) 1991-11-11
RU1829932C (ru) 1993-07-23
NO872729L (no) 1988-01-04
AR243893A1 (es) 1993-09-30
GB2192183A (en) 1988-01-06
ATA165887A (de) 1990-09-15
CN1015106B (zh) 1991-12-18
GB8715064D0 (en) 1987-08-05
NL193136B (nl) 1998-08-03
FI89052C (fi) 1993-08-10
DK336487A (da) 1988-01-03
CN87105009A (zh) 1988-03-23
HU200777B (en) 1990-08-28
NL8701507A (nl) 1988-02-01
ES2008759A6 (es) 1989-08-01
IL83059A (en) 1992-03-29
HUT44257A (en) 1988-02-29
GR871014B (en) 1987-11-02
FI872903A0 (fi) 1987-07-01
NZ220764A (en) 1989-09-27

Similar Documents

Publication Publication Date Title
IT8767566A0 (it) Idrato cristallino di acido 7 beta 72 2 amminotiazol 4 il 4 carbossi but 2 enoilammino 3 cefem 4 carbossilico procedimento per il suo ottenimento confezione per capsule di gelatina contenente detto idrato eprocedimento per l ottenimento di detta composizione
HUT48208A (en) Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
PT86974A (pt) Process for the preparation of imidazol compounds and of biociddal compositions containing the same
HUT45895A (en) Process for production of serotomin antagonic compounds and medical preparatives containing such compositions
HUT38341A (en) Process for producing benzoic acid derivatives and pharmaceutical compositions containing them
IT1226905B (it) Composti dell'acido solfonammidotienilcarbossilico
EP0427384A3 (en) Method of connecting tab tape to semiconductor chip
HUT40447A (en) Process for preparing substituted alpha-amino acids and pharmaceutical compositions containing such compounds
HUT45979A (en) Process for production of 5-phenil-2-oxasole-derivatives and medical compositions containing such compounds
PT79701A (en) Process for preparing delayed-action oral formulations of acid acetylsalicylic
HUT35653A (en) Process for preparing barbituric acid derivatives and anthelmintic compositions containing such compounds
IT1197330B (it) Procedimento per la sintesi di acido tauroursodesossicolico biidrato
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same
PL250497A1 (en) Method of obtaining novel derivatives of 2-/3-pyrridilo/-2-phenyloacetic acid and fungicide containing such compounds
IL81457A0 (en) Preparation of carboxylic acid amides
GB8815262D0 (en) Preparation of nucleic acid derivatives & medical compositions containing them
DE3660449D1 (en) Process for the preparation of amides of glycolic acid
HUT38094A (en) Process for preparing derivatives of n-/phenyl-3-methyl-thio-1-oxo-propyl/-amino-acetic acid and pharmaceutical compositions containing such compounds
IL87137A (en) Compositions for promoting the growth of animals comprising benzoylalkanoic acid and amide derivatives and some novel such compounds
PT83246A (en) Process for the preparation of pharmaceutical and/or veterinary compounds containing acid solutions 7 alpha-<2-/3- (3-chlorin-ephenoxy)-2-hydroxi-propyl>- 3 alpha 5 alpha-dihydroxi-cyclopentyl>-5-heptanoic and of its salt of sodium
YU289A (en) Process for obtaining salts of tetrazol 5-carbonic acid
EP0271212A3 (en) Process for preparation of carboxylic acid ester containing fluorine
GB8825422D0 (en) Crystallisation of sodium oxalates
IT1199103B (it) Procedimento per la preparazione dell'acido 1-naftol-4-solfonico
PL266620A1 (en) Method of obtaining 1-3-bromo-/2s/-methylpropionyl -pyrrolidine-/2s/-carboxylic acid of formula 1 and its monohydride

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 85

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 85, 19920402; SHIONOGI SEIYAKU KABUSHIKI KAISHA ( SHIONOGI & CO. LTD.)

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950731